Hepatocellular adenoma
For patient information, click here
| Hepatocellular adenoma | |
 | |
|---|---|
| MRI: T2 Fat sat. A patient with multiple adenoma. Image courtesy of RadsWiki | |
| ICD-O: | Template:ICDO |
| DiseasesDB | 5726 |
| MeSH | D018248 |
|
Hepatocellular adenoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hepatocellular adenoma On the Web |
|
American Roentgen Ray Society Images of Hepatocellular adenoma |
|
Risk calculators and risk factors for Hepatocellular adenoma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., PhD., Nawal Muazam M.D.[2]
Synonyms and keywords: Hepadenoma; hepatic adenoma; Liver adenoma; Liver cell adenoma
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Drud Side Effect
Drospirenone and Ethinyl estradiol, Norethindrone acetate and Ethinyl estradiol, Norgestimate and Ethinyl estradiol, Norgestrel and Ethinyl estradiol
Epidemiology and Demographics
Hepatocellular adenoma commonly affects women of child-bearing age often with a history of long-term use of oral contraceptive drugs.
Risk Factors
Screening
Differentiating Hepatocellular adenoma from other Diseases
Natural History, Complications and Prognosis
Diagnosis
Staging | History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Contraindicated medications
Hepatic adenoma is considered an absolute contraindication to the use of the following medications:
- Drospirenone and Ethinyl estradiol
- Norethindrone acetate and Ethinyl estradiol
- Norgestimate and Ethinyl estradiol
- Norgestrel and Ethinyl estradiol